Inventor
YASUTOMI ASANO
Inventor
JP
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes27%
C12YEnzymes3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
12,522,603Inhibitors of gas for treating autoinflammatory diseases and cancer metastasis202612,478,616PI3K inhibitors and uses thereof202512,378,256Heterocyclic compound202512,162,864Condensed-cyclic compound202412,084,436Heterocyclic compound202412,012,419Heterocyclic compound202411,970,483Heterocyclic compound202411,414,422Substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles as inhibitors of cGAS202211,279,713Heterocyclic compound and use thereof202211,236,099Heterocyclic compound2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (7)· patent assignee history
2022–2026Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (2)· patent assignee history
2022–2026Patents assigned to UNIV ROCKEFELLER (2)· patent assignee history
2022–2026Based in JP· patent location history
2025Patents assigned to SLOAN KETTERING INST CANCER RES (1)· patent assignee history
2025Patents assigned to TRI INST THERAPEUTICS DISCOVERY INST INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 7 | 2022–2025 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 2 | 2022–2026 |
| UNIV ROCKEFELLER | 2 | 2022–2026 |
| SLOAN KETTERING INST CANCER RES | 1 | 2025 |
| TRI INST THERAPEUTICS DISCOVERY INST INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 10 | 2022–2026 |